England's anticancer take-up is more uniform
This article was originally published in Scrip
Executive Summary
Cancer drugs are being used more evenly across England than they were in 2005, and overall use of approved drugs is increasing. These two trends emerge from a report by Professor Mike Richards, the national cancer director.